Belgium· BE-AMP-SAM662108-00
Veoza 45 mg
A fezolinetant product containing fezolinetant, registered in Belgium by Astellas Pharma Europe. The same ATC class is registered in 14 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Fezolinetant is registered in 14 of 19 countries.
Countries holding a registration under ATC G02CX06 (fezolinetant), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 9 of them publish a price we can compare per daily dose
Fezolinetant · ATC G02CX06
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of fezolinetant costs, country by country.
Normalised to the WHO defined daily dose (45 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Fezolinetant · price per daily dose (45 mg)
USD · FX 28 Sept 2026
- ES Spain$3.02
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Fezolinetant
- Manufacturer
- Astellas Pharma Europe
- Country
- Belgium (BE)
- ATC code
- G02CX06
- ATC class
- Fezolinetant
- Defined daily dose
- 45 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb4749040
- be_apb4749057
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fezolinetant in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVEOZAAstellas Pharma Europe B.V., Leiden
- United StatesVEOZAHAstellas Pharma US, Inc.
- SwitzerlandVeoza 45 mg, FilmtablettenAstellas Pharma AG
- FinlandVeozaAstellas Pharma Europe B.V.
- FranceVEOZA 45 mg, comprimé pelliculéASTELLAS PHARMA EUROPE (PAYS-BAS)
- IrelandVeoza 45 mg film-coated tabletsAstellas Pharma Europe B.V.
- IcelandVeozaAstellas Pharma Europe B.V.
- NetherlandsVeoza 45 mg filmomhulde tablettenAstellas Pharma Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Veoza
- Liechtenstein · Veoza
- Norway · Veoza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3d16fa98-6cc5-4e98-b4de-1e228cf11d36 GET /v1/drugs/3d16fa98-6cc5-4e98-b4de-1e228cf11d36?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Veoza 45 mg",
"name_fr": "Veoza 45 mg",
"name_nl": "Veoza 45 mg",
"amp_code": "SAM662108-00",
"strengths": [
"45.0000",
"45.0000"
],
"pack_count": 4,
"substances": [
"Fezolinetant",
"Mannitol"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Fezolinetant",
"authorisation_numbers": [
"EU/1/23/1771/002",
"EU/1/23/1771/003",
"EU/1/23/1771/001",
"EU/1/23/1771/004"
]
}See everything about fezolinetant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.